This study aimed to develop and validate a prognostic risk model by screening the immune checkpoint molecule HLA-G and its DEGs in cervical cancer based on RNA sequencing (RNA-seq) and the TCGA dataset by a series of bioinformatics methods. This evidence concerns the gene HLA-G and cervical carcinoma.